drug
as of 2026-07-01HS-10380 Medium dose
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Jiangsu Hansoh Pharmaceutical Co., Ltd.
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia
NCT07550387Phase 2Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication